Dr. Patrick Michael Azcarate, MD

Dr. Azcarate practices at Baptist Health Baptist Hospital in Miami, Florida, part of Baptist Health South Florida.

Dr. Azcarate's NPI, 1922460427, was assigned on March 23, 2016. Dr. Azcarate graduated from University of Miami, Miller School of Medicine in 2016. Dr. Azcarate holds Florida license ME155096.

Dr. Azcarate's primary practice is Baptist Health Baptist Hospital, at 8900 N Kendall Dr, Miami, FL 33176 in Miami-Dade County. The practice phone is (786) 596-1960.

Dr. Azcarate's primary practice is Baptist Health Baptist Hospital in Miami, Florida, part of Baptist Health South Florida. Dr. Azcarate is also affiliated with South Miami Hospital. The medical group on file is Baptist Health Medical Group. Dmand AI also links Dr. Azcarate to 3 more hospitals, 4 group practices and clinics, 3 medical groups and 1 breast imaging center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Azcarate practices, 10 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Azcarate's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Azcarate is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Azcarate's licenses on file in 2 states: Florida and California.

Dmand AI lists atrial fibrillation and flutter, chronic embolism thrombosis, chronic hypertension, coronary artery disease, heart blockage, heart failure, heart valve disorders and high cholesterol among the conditions Dr. Azcarate treats.

CMS data shows 1,016 Medicare services from Dr. Azcarate across 12 procedure codes in 2024, for 641 Medicare patients. Medicare paid $60,980 for them.

CMS counts 641 Medicare patients who saw Dr. Azcarate in 2024. The largest group is 75 to 84, with 211 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 2.47, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Azcarate's median patient age at 67, with 52% women.

In 2024, Dr. Azcarate wrote 3,112 Medicare Part D claims for 409 patients. 87% of them were for generic drugs. CMS names the drug for 2,876 of them, across 35 drugs with 11 or more claims each, at $312,550 in total drug cost. In 2023, CMS named 1,194 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Azcarate for performance year 2024, reported through an alternative payment model (APM). Dr. Azcarate accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Azcarate as offering telehealth.

Dmand AI links 7 papers to Dr. Azcarate, published from 2014 to 2020. 2014 was the busiest year, with 2. The most frequent topics are Lipoprotein(a). Dr. Azcarate has published most often in JAMA Intern Med. Dr. Azcarate's most frequent co-authors are Kara Marie Cavuoto, MD, Ta Chen Peter Chang, MD and Beth Ellen Cohen, MD.

CMS Open Payments shows 46 general payments to Dr. Azcarate from 17 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 99% of the total. Boston Scientific Corporation paid the most, $819.

Dr. Azcarate graduated from University of Miami, Miller School of Medicine in 2016.

Dr. Azcarate is in network with 10 carriers, including Elevance, Aetna and United Healthcare. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.